赛诺医疗
(688108)
| 流通市值：45.44亿 | | | 总市值：45.44亿 |
| 流通股本：4.13亿 | | | 总股本：4.13亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 318,486,443.24 | 213,692,262.55 | 91,062,636.9 | 343,257,735.55 |
| 营业收入 | 318,486,443.24 | 213,692,262.55 | 91,062,636.9 | 343,257,735.55 |
| 二、营业总成本 | 355,578,619.17 | 238,544,415.05 | 114,616,671.01 | 417,456,565.2 |
| 营业成本 | 123,276,333.08 | 87,193,779.96 | 41,581,816.74 | 141,025,595.72 |
| 税金及附加 | 2,059,947.27 | 1,527,928.92 | 653,176.27 | 2,257,921.11 |
| 销售费用 | 55,039,586.14 | 37,006,450.01 | 16,580,041 | 63,198,787.52 |
| 管理费用 | 65,686,835.82 | 42,441,456.03 | 18,778,575.35 | 94,568,065.74 |
| 研发费用 | 106,407,498.18 | 68,264,921.24 | 36,009,056.49 | 114,095,491.84 |
| 财务费用 | 3,108,418.68 | 2,109,878.89 | 1,014,005.16 | 2,310,703.27 |
| 其中:利息费用 | 4,197,871.37 | 2,817,804.57 | 1,409,377.37 | 3,748,086.73 |
| 其中:利息收入 | 1,681,037.77 | 1,114,478.6 | -608,543.72 | 2,632,251.08 |
| 加:公允价值变动收益 | - | - | 38,732.23 | - |
| 加:投资收益 | 20,782,784.14 | 20,782,784.14 | 20,714,206.35 | -4,673,372.13 |
| 资产处置收益 | - | - | - | -1,406,057.97 |
| 资产减值损失(新) | -7,904,949.4 | -3,220,337.35 | -3,640,746.56 | -4,611,904.58 |
| 信用减值损失(新) | 113,867.28 | -102,641.31 | 29,434.59 | 1,405,569.58 |
| 其他收益 | 16,564,853.19 | 11,676,247.92 | 7,542,401.31 | 14,067,287.08 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -7,535,620.72 | 4,283,900.9 | 1,129,993.81 | -69,417,307.67 |
| 加:营业外收入 | 653,763.92 | 586,507.4 | 387,227.42 | 1,818,392.13 |
| 减:营业外支出 | 254,128.28 | 17,544.84 | 17,214.5 | 257,530.63 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -7,135,985.08 | 4,852,863.46 | 1,500,006.73 | -67,856,446.17 |
| 减:所得税费用 | -1,792,789.37 | -4,921,615.22 | -4,403,521.28 | -24,456,659.01 |
| 六、净利润 | -5,343,195.71 | 9,774,478.68 | 5,903,528.01 | -43,399,787.16 |
| 持续经营净利润 | -5,343,195.71 | 9,774,478.68 | 5,903,528.01 | -40,562,271 |
| 终止经营净利润 | - | - | - | -2,837,516.16 |
| 归属于母公司股东的净利润 | -6,744,452.88 | 7,662,008.81 | 2,498,599.75 | -39,630,042.94 |
| 少数股东损益 | 1,401,257.17 | 2,112,469.87 | 3,404,928.26 | -3,769,744.22 |
| (一)基本每股收益 | -0.02 | 0.02 | 0.01 | -0.1 |
| (二)稀释每股收益 | -0.02 | 0.02 | 0.01 | -0.1 |
| 八、其他综合收益 | -1,557,247.2 | -1,149,046.93 | -1,318,944.11 | 448,558.25 |
| 归属于母公司股东的其他综合收益 | -1,557,247.2 | -1,149,046.93 | -1,318,944.11 | 448,558.25 |
| 九、综合收益总额 | -6,900,442.91 | 8,625,431.75 | 4,584,583.9 | -42,951,228.91 |
| 归属于母公司股东的综合收益总额 | -8,301,700.08 | 6,512,961.88 | 1,179,655.64 | -39,181,484.69 |
| 归属于少数股东的综合收益总额 | 1,401,257.17 | 2,112,469.87 | 3,404,928.26 | -3,769,744.22 |
| 公告日期 | 2024-10-30 | 2024-08-20 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |